Jan Novak mostly deals with Immunology, Nephropathy, Glomerulonephritis, Immunoglobulin A and Antibody. His Nephropathy research is multidisciplinary, relying on both Biomarker, Genetics, Internal medicine, Case-control study and Genome-wide association study. He has researched Internal medicine in several fields, including Gastroenterology, Endocrinology and Immune complex.
His Glomerulonephritis research includes elements of Kidney disease, Nephritis and Immunopathology. His Immunoglobulin A study is associated with Immunoglobulin G. His Antibody research incorporates elements of Pathogenesis, Glycosylation, Immune system, Molecular biology and Flagellin.
His main research concerns Nephropathy, Immunology, Internal medicine, Immune system and Glomerulonephritis. In his research, Bioinformatics is intimately related to Disease, which falls under the overarching field of Nephropathy. Jan Novak interconnects Biomarker and Biomarker discovery in the investigation of issues within Bioinformatics.
His Kidney research extends to the thematically linked field of Immunology. His biological study spans a wide range of topics, including Gastroenterology, Endocrinology and Cardiology. As a part of the same scientific family, Jan Novak mostly works in the field of Antibody, focusing on Glycosylation and, on occasion, Glycan, Lectin and Receptor.
His primary scientific interests are in Internal medicine, Nephropathy, Cardiology, Immune system and Immunology. The Internal medicine study combines topics in areas such as Gastroenterology and Diabetes mellitus. He has included themes like Glomerulonephritis, Kidney, Membranous nephropathy, Disease and IgA vasculitis in his Nephropathy study.
The concepts of his Immune system study are interwoven with issues in Autoantibody, Cancer research, Glycosylation and Computational biology. His Autoantibody study integrates concerns from other disciplines, such as Proteinuria, Pathogenesis and Renal biopsy. As part of his studies on Immunology, Jan Novak often connects relevant subjects like Galactose.
Jan Novak spends much of his time researching Nephropathy, Immune system, Internal medicine, Immunology and Glycosylation. His Nephropathy research integrates issues from Glomerulonephritis, Kidney, Membranous nephropathy, Autoantibody and Disease. His work deals with themes such as Proteinuria, Pathogenesis and Renal biopsy, which intersect with Autoantibody.
Jan Novak is interested in Immune complex, which is a branch of Immune system. In the subject of general Internal medicine, his work in Cohort, Prospective cohort study, Renal function and Endomyocardial biopsy is often linked to In patient, thereby combining diverse domains of study. His studies deal with areas such as Receptor, Antibody and Glycan as well as Glycosylation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Glycosylation in health and disease.
Colin Reily;Tyler J. Stewart;Matthew B. Renfrow;Jan Novak.
Nature Reviews Nephrology (2019)
The Pathophysiology of IgA Nephropathy
Hitoshi Suzuki;Krzysztof Kiryluk;Jan Novak;Zina Moldoveanu.
Journal of The American Society of Nephrology (2011)
Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies
Milan Tomana;Jan Novak;Bruce A. Julian;Karel Matousovic.
Journal of Clinical Investigation (1999)
Genome-wide association study identifies susceptibility loci for IgA nephropathy
Ali G Gharavi;Krzysztof Kiryluk;Murim Choi;Yifu Li.
Nature Genetics (2011)
Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens
Krzysztof Kiryluk;Yifu Li;Francesco Scolari;Simone Sanna-Cherchi.
Nature Genetics (2014)
Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease
David M. Good;Petra Zürbig;Àngel Argilés;Hartwig W. Bauer.
Molecular & Cellular Proteomics (2010)
Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity
Hitoshi Suzuki;Run Fan;Zhixin Zhang;Rhubell Brown.
Journal of Clinical Investigation (2009)
Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels.
Z. Moldoveanu;R.J. Wyatt;J.Y. Lee;M. Tomana.
Kidney International (2007)
Muscle-specific microRNAs in skeletal muscle development
Martin Horak;Jan Novak;Julie Bienertova-Vasku.
Developmental Biology (2016)
Clinical proteomics: A need to define the field and to begin to set adequate standards.
Harald Mischak;Rolf Apweiler;Rosamonde E. Banks;Mark Conaway.
Proteomics Clinical Applications (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: